ELAVL4 is a gene/protein that plays a critical role in neurodegenerative disease. It is located on chromosome 1p31.3 and catalogued as NCBI Gene ID 1992.
ELAVL4 (HuD) is an RNA-binding protein essential for neuronal development and function. It is implicated in ALS and neurodegenerative diseases.
Elavl4 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| ELAV-Like Protein 4 | |
|---|---|
| Gene Symbol | ELAVL4 |
| Full Name | ELAV Like Neuron-Specific RNA Binding Protein 4 |
| Chromosome | 1p34.2 |
| NCBI Gene ID | 1998 |
| OMIM | 168603 |
| Ensembl ID | ENSG00000162374 |
| UniProt ID | P26378 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis |
ELAVL4 encodes ELAV-like protein 4 (also known as HU antigen D), a neuron-specific RNA-binding protein. Like other ELAVL family members, ELAVL4 regulates mRNA stability, splicing, and translation. It is particularly important for neuronal differentiation, synaptic plasticity, and has been implicated in various neurodegenerative diseases.
Neuron-specific expression with high levels in hippocampus, cortex, and cerebellum. Important for maintaining neuronal identity.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Alzheimer's Disease | Risk variants | Risk factor | Synaptic plasticity dysregulation, APP processing |
| Parkinson's Disease | Risk variants | Risk factor | Dopaminergic neuron survival |
| ALS | Risk variants | Risk factor | RNA metabolism impairment |
The study of Elavl4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
ELAVL4 (also known as HuD) is a member of the ELAV-like family of RNA-binding proteins that includes ELAVL1 (HuR), ELAVL2 (HuB), ELAVL3 (HuC), and ELAVL4 (HuD). These proteins are characterized by their ability to bind to adenine-uridine-rich elements (AU-rich elements, AREs) in the 3' untranslated regions (3'UTRs) of target mRNAs, thereby regulating mRNA stability, localization, and translation.
In neurons, ELAVL4 plays several critical functions:
mRNA Stabilization: ELAVL4 binds to AREs in neuronal mRNAs, protecting them from degradation and extending their half-life. Target mRNAs include those encoding synaptic proteins (synapsin I, GAP-43, tau), transcription factors (c-Fos, N-myc), and proteins involved in neuronal differentiation.
Synaptic Plasticity: Through regulation of synaptic protein expression, ELAVL4 contributes to long-term potentiation (LTP) and memory formation. Studies show that ELAVL4 knockout mice exhibit deficits in spatial memory and synaptic plasticity.
Neuronal Development: ELAVL4 is essential for neuronal differentiation and survival. It promotes expression of genes involved in neurogenesis, axon guidance, and synapse formation.
Axonal mRNA Transport: ELAVL4 facilitates transport of target mRNAs along axons to distal synaptic terminals, where local translation occurs. This is critical for synaptic maintenance and plasticity.
ELAVL4 is predominantly expressed in neurons of the central and peripheral nervous systems. High expression is observed in:
During development, ELAVL4 expression increases during neuronal differentiation and peaks in the adult brain, indicating its importance in mature neuronal function.
ELAVL4 is genetically and functionally linked to ALS pathogenesis:
ELAVL4 may contribute to PD pathogenesis through several mechanisms:
Evidence suggests ELAVL4 involvement in AD:
ELAVL4 represents a potential therapeutic target for neurodegenerative diseases:
ELAVL4 participates in several key pathways:
Key protein interactions include:
Bolognani F, Perrone-Bizzozero NI. RNA-protein interactions and control of mRNA stability in neurons. J Neurosci Res. 2008;86(3):481-489. PMID:17918743
Fallini C, Bassell GJ, Rossoll W. The ALS disease protein TDP-43 is transported into neurites and localizes in a complex with Sm proteins in motor neurons. J Neurochem. 2012;122(4):741-751. PMID:22564355
Ince PG, Highley JR, Kirby J, et al. Molecular pathology and genetic advances in ALS: an integrated review. J Neurol Neurosurg Psychiatry. 2019;90(3):263-270. PMID:30642966
Ito D, Hatakeyama M, Kondo S, et al. Human ELAVL4 gene mutations cause a novel form of progressive cerebellar ataxia. J Neurol. 2020;267(11):3247-3256. PMID:32666241
Kim SH, Shanware NP, Bowler MJ, Tibbetts RS. ALS-associated proteins TDP-43 and FUS interact with and modulate the function of ELAV-like proteins. J Biol Chem. 2013;288(47):33925-33938. PMID:24047896
Lu L, Wang L, Liu J, et al. ELAVL4 modulates mitochondrial dynamics and mitophagy in neuronal cells. Cell Mol Neurobiol. 2022;42(7):2241-2255. PMID:34296328
Mercado PA, Ayala YM, Romano M, et al. Depletion of TDP-43 overrides the need for other RNA-binding proteins in Drosophila neuromuscular junctions. Nat Commun. 2020;11:3498.
Liu W, Venugopal P, Barmada S, et al. ELAVL4 regulates neuronal RNA metabolism and synaptic plasticity in health and disease. Neurobiol Dis. 2023;178:106027.